Here's all that happened in the market today
The stock slipped 6% to Rs 599 on the BSE in intra-day trade.
In past one month, Nifty Metal index underperformed the market by falling 10.5% against 3.6% decline in Nifty 50 index
While Bitcoins got most attention, 2017 has been a remarkable year for other cryptocurrencies as well
The company wants to invest more in the government securities as it will be beneficial for policyholders and pensioners.
The stock surged 12% to Rs 478, also its record high on the BSE, after the company announced that its board will meet on Friday, December 8, 2017 to consider fund raising plans
On December 5, 2017, Nirmal Bhanwarlal Jain, purchased 128,520 equity shares representing 1% stake of 5Paisa Capital at price of Rs 191.22 per share on NSE.
During the first six months of that period, LIC's stock market investments more than doubled from a year earlier to 392.24 billion rupees
The stock hit a new high of Rs 662, up 8% on the BSE in early morning trade, after the company reported 13% growth in net profit at Rs 13.33 crore in September quarter
Promoters and PE investor, Griffin, will together sell 24.43% stake through the IPO, which closes on December 8.
The virtual currency's price has run up very fast and experts feel a correction may be around the corner
Nifty outlook and key trading ideas by Vaishali Parekh, Research Analyst - Technical Research at Prabhudas Lilladher
Nifty outlook and key trading ideas by Devarsh Vakil & Vinay Rajani - PCG Desk, HDFC securities
Sebi softens stand after India Inc, lenders express concern
Halol plant clearance, approval of specialty products are triggers going ahead
Merger with Videocon D2H, extracting synergy gains of Rs 510 cr in FY19, crucial
Nifty, Bank Nifty, HDFC, Hero MotoCorp, BPCL
ICICI Securities says the recent weakness is over 'concerns that are short-term in nature and are not structural impediments to growth, thereby providing entry points to long-term investors'
In the past one year, average return of FMCG category was 41%, at a time key benchmarks returned 25% to investors
The biosimilars torchbearer added Rs 21,000 crore to its m-cap over the past two years